Home › Funds › ADAPT Investment Managers SA › GILD
ADAPT Investment Managers SA position in GILD
GILEAD SCIENCES INC · Health Care
ADAPT Investment Managers SA reported holding 100,000 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$14.9M, representing 0.28% of its reported portfolio and ranking #41 among its reported holdings. ADAPT Investment Managers SA has disclosed GILD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ADAPT Investment Managers SA's GILD position evolved
ADAPT Investment Managers SA first disclosed a stake in GILD in Q1 2026 at 63,165 shares (US$8.8M). The position peaked in Q3 2026 at 100,000 shares, worth US$14.9M. Across 3 filings, ADAPT Investment Managers SA increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 100,000 shares valued at US$14.9M — an increase of 61,635 shares quarter over quarter.. Notable position changes include a 39% trim in Q2 2026 (shares rose 18% over the following quarter), a 161% increase in Q3 2026 (shares rose 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 63.16K | $8.80M | New |
| Q2 2026 | 38.37K | $4.85M | Reduce |
| Q3 2026 | 100.00K | $14.90M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 58.27M sh · $8.68B · Q3 2026
- Invesco Ltd 38.66M sh · $5.76B · Q3 2026
- Capital World Investors 35.93M sh · $5.36B · Q3 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Capital Research Global Investors 23.98M sh · $3.57B · Q3 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
- MFS Investment Management 11.46M sh · $1.77B · Q3 2026
- Amundi US 11.26M sh · $1.68B · Q3 2026
- Deutsche Bank AG 9.61M sh · $1.43B · Q3 2026
- Boston Partners 6.52M sh · $970.37M · Q3 2026
More on ADAPT Investment Managers SA
FAQ
How long has ADAPT Investment Managers SA held GILD?
ADAPT Investment Managers SA has disclosed GILD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is ADAPT Investment Managers SA's current position in GILD?
As of Q3 2026, ADAPT Investment Managers SA holds 100.00K shares of GILD (GILEAD SCIENCES INC), valued at $14.90M, representing 0.28% of its reported portfolio and ranking #41.
Has ADAPT Investment Managers SA been buying or selling GILD?
In the latest 13F filing (Q3 2026), ADAPT Investment Managers SA increased its position in GILD. The position peaked in Q3 2026 at 100.00K shares.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.